Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of PROCRIT® (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks
This study has been completed.
Study NCT00337948.   Last updated on October 11, 2007.
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Chemotherapy
Anemia
More general conditions related to this trial
Hematologic Diseases
Interventions listed in this trial
Epoetin alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Ortho Biotech, Inc.


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services